Pfizer settlement and Bextra whistleblower case
News stories and court documents

Newstories

• "Pfizer whistleblower's ordeal reaps big rewards," Reuters, Bill Berkrot, Sept. 2, 2009.
• "Pfizer to Pay Record Penalty In Improper-Marketing Case," Carrie Johnson, Washington Post, September 3, 2009.
• "Pfizer fined $2.3 billion for illegal marketing in off-label drug case," Rita Rubin, USA Today, Sept. 3, 2009.
• "Pfizer Pays $2.3 Billion to Settle Marketing Case," Gardiner Harris, The New York Times, Sept. 3, 2009.
• "Pfizer's West Side Story: How the Sharks Sold Bextra Off-Label," Jim Edwards, BNET.com.
• "Pfizer Settles Criminal, Civil Claims for $2.3 Billion," Legal Times, Sept. 2, 2009.
• BBC Newshour interview with Phillips & Cohen attorney Erika Kelton about the Pfizer settlement and Bextra qui tam case.
• BBC World Today interview with whistleblower John Kopchinski about his qui tam lawsuit that exposed off-label marketing of Bextra.

Court documents

• United States Sentencing Memorandum (United States v. Pharmacia & Upjohn Company, Inc., Criminal Number 09 CR 10258-DPW; dated 10/09/09) 
• Qui tam complaint (United States ex rel. John Kopchinski v. Pfizer Inc., et al., 05-CV-12115-RCL, D. Mass.; settlement 9/02/09)
• Exhibits with Kopchinski qui tam complaint
• Indictment of Pfizer district manager on aiding and abetting and obstruction charges

• Indictment of Pfizer regional manager for introduction into interstate commerce of a misbranded drug.